Value of three-dimensional speckle-tracking imaging in detecting left ventricular systolic function in patients with

Jionghong He1, Long Yang1

  • 1Department of Cardiology, Guizhou Provincial People's Hospital, Guiyang, China.

Insights

Three-dimensional speckle-tracking imaging (3DSTI) accurately assesses left ventricular systolic function in dilated cardiomyopathy (DCM) patients. Its left ventricular ejection fraction (LVEF) measurements closely align with cardiac magnetic resonance imaging (MRI) findings.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Biomedical Engineering

Background:

  • Dilated cardiomyopathy (DCM) is a significant cause of heart failure.
  • Accurate assessment of left ventricular systolic function is crucial for DCM management.
  • Traditional imaging methods may have limitations in quantifying cardiac function.

Purpose of the Study:

  • To evaluate the diagnostic value of three-dimensional speckle-tracking imaging (3DSTI) for left ventricular systolic function in DCM patients.
  • To compare 3DSTI measurements with established methods like two-dimensional echocardiography (2DE) and magnetic resonance imaging (MRI).

Main Methods:

  • Thirty-one DCM patients were included in the study.
  • Left ventricular volumes (LVESV, LVEDV) and ejection fraction (LVEF) were measured using 3DSTI, 2DE, and MRI.
  • Left ventricular end-diastolic mass (EDmass) and index (EDmassI) were also assessed by 3DSTI and MRI.

Main Results:

  • Positive correlations were observed for LVESV, LVEDV, and LVEF across all three imaging modalities.
  • Significant differences in LVEF were found among the groups (3DSTI: 30.3 ± 10.6%, MRI: 26.2 ± 10.7%, P=0.04).
  • 3DSTI measurements for EDmass and EDmassI were significantly lower compared to MRI (P < 0.001).

Conclusions:

  • Three-dimensional speckle-tracking imaging (3DSTI) demonstrates reliable performance in assessing left ventricular systolic function in DCM.
  • 3DSTI-derived LVEF values show closer agreement with MRI than with 2DE.
  • 3DSTI offers a promising non-invasive tool for evaluating cardiac function in DCM.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
492
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
488
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
433
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
521
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
321
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
361